Evidence map›Paper›PMID 30371266›Full record

ArticleJournal of the American Heart Association2018

Molecular Atlas of Postnatal Mouse Heart Development.

Virpi Talman, Jaakko Teppo, Päivi Pöhö, Parisa Movahedi, Anu Vaikkinen, S Tuuli Karhu, Kajetan Trošt, Tommi Suvitaival, Jukka Heikkonen, Tapio Pahikkala and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. α Protein Kinase 3 Is Essential for Neonatal and Adult Cardiac Function.Journal of the American Heart Association · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Virpi Talman1 Drug Research Program and Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy University of Helsinki Finland.
Jaakko Teppo2 Drug Research Program and Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Finland.
Päivi Pöhö2 Drug Research Program and Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Finland.
Parisa Movahedi4 Department of Future Technologies Faculty of Mathematics and Natural Sciences University of Turku Finland.
Anu Vaikkinen2 Drug Research Program and Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Finland.
S Tuuli Karhu1 Drug Research Program and Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy University of Helsinki Finland.
Kajetan Trošt5 Steno Diabetes Center Copenhagen Gentofte Denmark.
Tommi Suvitaival5 Steno Diabetes Center Copenhagen Gentofte Denmark.
Jukka Heikkonen4 Department of Future Technologies Faculty of Mathematics and Natural Sciences University of Turku Finland.
Tapio Pahikkala4 Department of Future Technologies Faculty of Mathematics and Natural Sciences University of Turku Finland.
Tapio Kotiaho2 Drug Research Program and Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Finland.
Risto Kostiainen2 Drug Research Program and Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Finland.
Markku Varjosalo3 Institute of Biotechnology and HiLIFE Helsinki Institute of Life Science University of Helsinki Finland.
Heikki Ruskoaho1 Drug Research Program and Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy University of Helsinki Finland.
University of Helsinki · FIUniversity of Turku · FISteno Diabetes Center · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The molecular mechanisms mediating postnatal loss of cardiac regeneration in mammals are not fully understood. We aimed to provide an integrated resource of mRNA , protein, and metabolite changes in the neonatal heart for identification of metabolism-related mechanisms associated with cardiac regeneration. Methods and Results Mouse ventricular tissue samples taken on postnatal day 1 (P01), P04, P09, and P23 were analyzed with RNA sequencing and global proteomics and metabolomics. Gene ontology analysis, KEGG pathway analysis, and fuzzy c-means clustering were used to identify up- or downregulated biological processes and metabolic pathways on all 3 levels, and Ingenuity pathway analysis (Qiagen) was used to identify upstream regulators. Differential expression was observed for 8547 mRNA s and for 1199 of 2285 quantified proteins. Furthermore, 151 metabolites with significant changes were identified. Differentially regulated metabolic pathways include branched chain amino acid degradation (upregulated at P23), fatty acid metabolism (upregulated at P04 and P09; downregulated at P23) as well as the HMGCS ( HMG -CoA [hydroxymethylglutaryl-coenzyme A] synthase)-mediated mevalonate pathway and ketogenesis (transiently activated). Pharmacological inhibition of HMGCS in primary neonatal cardiomyocytes reduced the percentage of BrdU-positive cardiomyocytes, providing evidence that the mevalonate and ketogenesis routes may participate in regulating the cardiomyocyte cell cycle. Conclusions This study is the first systems-level resource combining data from genomewide transcriptomics with global quantitative proteomics and untargeted metabolomics analyses in the mouse heart throughout the early postnatal period. These integrated data of molecular changes associated with the loss of cardiac regeneration may open up new possibilities for the development of regenerative therapies.

Indexed as

Amino Acids, Branched-ChainAnimalsAnimals, NewbornFatty AcidsGene ExpressionHeartHeart VentriclesKetone BodiesMetabolomicsMevalonic AcidMiceProteomicsRNA, MessengerTranscriptomeAmino Acids, Branched-ChainFatty AcidsKetone BodiesMevalonic AcidRNA, Messengerheart developmentheart regenerationmetabolomicsneonatal mouse cardiomyocyteproteomicstranscriptomics

Identifiers

PMID30371266
PMCPMC6474944
OpenAlexW2951043975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.